Prognosis of Acral Melanoma: A Series of 281 Patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-07-10

AUTHORS

Danielle M. Bello, Joanne F. Chou, Katherine S. Panageas, Mary S. Brady, Daniel G. Coit, Richard D. Carvajal, Charlotte E. Ariyan

ABSTRACT

BackgroundAcral melanoma (AM) is an unusual malignancy with poor survival. This study defines a cohort of patients, treated at a single institution, and the factors associated with survival and comparison with nonacral cutaneous melanoma (NACM).MethodsAll patients with AM presenting from 1995 to 2010 were identified from a prospectively maintained database. Analysis of clinicopathologic features of AM associated with disease-specific survival (DSS) was performed. A stratified, stage-matched survival analysis compared the outcome of 281 acral to 843 extremity NACM patients.ResultsA total of 281 AM patients (170 volar, 111 subungual) were identified. Pathologic stage (p < 0.001), ulceration (p < 0.001), Breslow thickness (p < 0.001), and a positive sentinel lymph node (p < 0.001) were found to be poor prognostic indicators associated with DSS. In stage-matched analysis, AM had a worse DSS compared with NACM (hazard ratio 1.8; 95 % CI 1.2–2.7; p < 0.01).ConclusionsThis study represents the largest, single-institution series describing the characteristics and outcomes of AM. AM tumors exhibit aggressive histopathologic features associated with a poorer survival outcome. AM patients have an inferior survival than extremity NACM when matched for stage, perhaps reflecting inherent alterations in tumor biology. This warrants further investigation into the differences between acral and cutaneous melanoma. More... »

PAGES

3618-3625

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-013-3089-0

DOI

http://dx.doi.org/10.1245/s10434-013-3089-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049896977

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23838913


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bello", 
        "givenName": "Danielle M.", 
        "id": "sg:person.01236253014.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236253014.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chou", 
        "givenName": "Joanne F.", 
        "id": "sg:person.01050575541.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050575541.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Panageas", 
        "givenName": "Katherine S.", 
        "id": "sg:person.01356724235.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356724235.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brady", 
        "givenName": "Mary S.", 
        "id": "sg:person.01157103223.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157103223.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coit", 
        "givenName": "Daniel G.", 
        "id": "sg:person.0625226217.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625226217.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carvajal", 
        "givenName": "Richard D.", 
        "id": "sg:person.0726366600.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ariyan", 
        "givenName": "Charlotte E.", 
        "id": "sg:person.01242114114.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242114114.58"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1245/s10434-011-1706-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052825046", 
          "https://doi.org/10.1245/s10434-011-1706-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1008872014889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016443286", 
          "https://doi.org/10.1023/a:1008872014889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2005.03.074", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038975406", 
          "https://doi.org/10.1245/aso.2005.03.074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1757-1146-1-11", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050685050", 
          "https://doi.org/10.1186/1757-1146-1-11"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/b97377", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013400699", 
          "https://doi.org/10.1007/b97377"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.2359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021618497", 
          "https://doi.org/10.1038/ng.2359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10434-000-0160-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035530171", 
          "https://doi.org/10.1007/s10434-000-0160-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018460227927", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004366948", 
          "https://doi.org/10.1023/a:1018460227927"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-07-10", 
    "datePublishedReg": "2013-07-10", 
    "description": "BackgroundAcral melanoma (AM) is an unusual malignancy with poor survival. This study defines a cohort of patients, treated at a single institution, and the factors associated with survival and comparison with nonacral cutaneous melanoma (NACM).MethodsAll patients with AM presenting from 1995 to 2010 were identified from a prospectively maintained database. Analysis of clinicopathologic features of AM associated with disease-specific survival (DSS) was performed. A stratified, stage-matched survival analysis compared the outcome of 281 acral to 843 extremity NACM patients.ResultsA total of 281 AM patients (170 volar, 111 subungual) were identified. Pathologic stage (p\u00a0<\u00a00.001), ulceration (p\u00a0<\u00a00.001), Breslow thickness (p\u00a0<\u00a00.001), and a positive sentinel lymph node (p\u00a0<\u00a00.001) were found to be poor prognostic indicators associated with DSS. In stage-matched analysis, AM had a worse DSS compared with NACM (hazard ratio 1.8; 95\u00a0% CI 1.2\u20132.7; p\u00a0<\u00a00.01).ConclusionsThis study represents the largest, single-institution series describing the characteristics and outcomes of AM. AM tumors exhibit aggressive histopathologic features associated with a poorer survival outcome. AM patients have an inferior survival than extremity NACM when matched for stage, perhaps reflecting inherent alterations in tumor biology. This warrants further investigation into the differences between acral and cutaneous melanoma.", 
    "genre": "article", 
    "id": "sg:pub.10.1245/s10434-013-3089-0", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2705241", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "keywords": [
      "nonacral cutaneous melanoma", 
      "disease-specific survival", 
      "AM patients", 
      "cutaneous melanoma", 
      "stage-matched survival analysis", 
      "positive sentinel lymph nodes", 
      "worse disease-specific survival", 
      "stage-matched analysis", 
      "aggressive histopathologic features", 
      "cohort of patients", 
      "single-institution series", 
      "sentinel lymph nodes", 
      "poor prognostic indicator", 
      "poor survival outcomes", 
      "warrants further investigation", 
      "MethodsAll patients", 
      "AM tumors", 
      "unusual malignancy", 
      "lymph nodes", 
      "inferior survival", 
      "clinicopathologic features", 
      "pathologic stage", 
      "histopathologic features", 
      "survival outcomes", 
      "single institution", 
      "ResultsA total", 
      "prognostic indicator", 
      "poor survival", 
      "acral melanoma", 
      "patients", 
      "survival analysis", 
      "tumor biology", 
      "melanoma", 
      "ConclusionsThis study", 
      "survival", 
      "outcomes", 
      "inherent alterations", 
      "further investigation", 
      "ulceration", 
      "prognosis", 
      "malignancy", 
      "cohort", 
      "acral", 
      "tumors", 
      "AM", 
      "total", 
      "study", 
      "alterations", 
      "stage", 
      "factors", 
      "differences", 
      "database", 
      "analysis", 
      "features", 
      "series", 
      "indicators", 
      "institutions", 
      "biology", 
      "investigation", 
      "comparison", 
      "nodes", 
      "characteristics", 
      "thickness"
    ], 
    "name": "Prognosis of Acral Melanoma: A Series of 281 Patients", 
    "pagination": "3618-3625", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049896977"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-013-3089-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23838913"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-013-3089-0", 
      "https://app.dimensions.ai/details/publication/pub.1049896977"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_603.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1245/s10434-013-3089-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-013-3089-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-013-3089-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-013-3089-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-013-3089-0'


 

This table displays all metadata directly associated to this object as RDF triples.

256 TRIPLES      21 PREDICATES      109 URIs      93 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-013-3089-0 schema:about N0d3095fea0df42b8a99693c7128f19fc
2 N207bac4190574f9fbe7b8f67df3120e3
3 N552ad053cd0846cab77d39c5017b2985
4 N552c8e9faf6f43b1b8c0327e62c6077b
5 N589365064c884e83811b48d021b6470b
6 N5c7ac7a297984eb18fef522f94943d5a
7 N67e43da2200444bbae58eb35617a3bac
8 N74c7be69055b46ecb74640b3c97552f5
9 N859498c7489c4e4c93bff0bb8f66b839
10 Nb4aa9de988054f77b83551c6a530a35b
11 Nb5f3c57052e54cbfa3b91136c78c1de6
12 Ncf2c0839ac2345fa8dde1d8bc6ca01d4
13 Nebf551dcf5ef4bb592fffdec3fb821f8
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N4149360ca9154c77a6982a3675fb813d
17 schema:citation sg:pub.10.1007/b97377
18 sg:pub.10.1007/s10434-000-0160-4
19 sg:pub.10.1023/a:1008872014889
20 sg:pub.10.1023/a:1018460227927
21 sg:pub.10.1038/ng.2359
22 sg:pub.10.1186/1757-1146-1-11
23 sg:pub.10.1245/aso.2005.03.074
24 sg:pub.10.1245/s10434-011-1706-3
25 schema:datePublished 2013-07-10
26 schema:datePublishedReg 2013-07-10
27 schema:description BackgroundAcral melanoma (AM) is an unusual malignancy with poor survival. This study defines a cohort of patients, treated at a single institution, and the factors associated with survival and comparison with nonacral cutaneous melanoma (NACM).MethodsAll patients with AM presenting from 1995 to 2010 were identified from a prospectively maintained database. Analysis of clinicopathologic features of AM associated with disease-specific survival (DSS) was performed. A stratified, stage-matched survival analysis compared the outcome of 281 acral to 843 extremity NACM patients.ResultsA total of 281 AM patients (170 volar, 111 subungual) were identified. Pathologic stage (p < 0.001), ulceration (p < 0.001), Breslow thickness (p < 0.001), and a positive sentinel lymph node (p < 0.001) were found to be poor prognostic indicators associated with DSS. In stage-matched analysis, AM had a worse DSS compared with NACM (hazard ratio 1.8; 95 % CI 1.2–2.7; p < 0.01).ConclusionsThis study represents the largest, single-institution series describing the characteristics and outcomes of AM. AM tumors exhibit aggressive histopathologic features associated with a poorer survival outcome. AM patients have an inferior survival than extremity NACM when matched for stage, perhaps reflecting inherent alterations in tumor biology. This warrants further investigation into the differences between acral and cutaneous melanoma.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf Nd21be8f3c8ec431c87a6157dc1dfe175
31 Nd2ed499f2b5a48ce917213c11867f177
32 sg:journal.1105545
33 schema:keywords AM
34 AM patients
35 AM tumors
36 ConclusionsThis study
37 MethodsAll patients
38 ResultsA total
39 acral
40 acral melanoma
41 aggressive histopathologic features
42 alterations
43 analysis
44 biology
45 characteristics
46 clinicopathologic features
47 cohort
48 cohort of patients
49 comparison
50 cutaneous melanoma
51 database
52 differences
53 disease-specific survival
54 factors
55 features
56 further investigation
57 histopathologic features
58 indicators
59 inferior survival
60 inherent alterations
61 institutions
62 investigation
63 lymph nodes
64 malignancy
65 melanoma
66 nodes
67 nonacral cutaneous melanoma
68 outcomes
69 pathologic stage
70 patients
71 poor prognostic indicator
72 poor survival
73 poor survival outcomes
74 positive sentinel lymph nodes
75 prognosis
76 prognostic indicator
77 sentinel lymph nodes
78 series
79 single institution
80 single-institution series
81 stage
82 stage-matched analysis
83 stage-matched survival analysis
84 study
85 survival
86 survival analysis
87 survival outcomes
88 thickness
89 total
90 tumor biology
91 tumors
92 ulceration
93 unusual malignancy
94 warrants further investigation
95 worse disease-specific survival
96 schema:name Prognosis of Acral Melanoma: A Series of 281 Patients
97 schema:pagination 3618-3625
98 schema:productId N15702dd27dfc405b9c943944632410ea
99 N197eb36711bf419ca730614d75bebd30
100 Nae28958ec61349c9b1b4af5c9993377a
101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049896977
102 https://doi.org/10.1245/s10434-013-3089-0
103 schema:sdDatePublished 2022-12-01T06:31
104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
105 schema:sdPublisher Nf5823b9ce68e4fbc81e221a628684fdc
106 schema:url https://doi.org/10.1245/s10434-013-3089-0
107 sgo:license sg:explorer/license/
108 sgo:sdDataset articles
109 rdf:type schema:ScholarlyArticle
110 N004d71607f8a4e23acceecda9618f1a3 rdf:first sg:person.0625226217.29
111 rdf:rest Nba3a2376b19c4ce28de036135882e308
112 N0d3095fea0df42b8a99693c7128f19fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Melanoma
114 rdf:type schema:DefinedTerm
115 N15702dd27dfc405b9c943944632410ea schema:name doi
116 schema:value 10.1245/s10434-013-3089-0
117 rdf:type schema:PropertyValue
118 N197eb36711bf419ca730614d75bebd30 schema:name dimensions_id
119 schema:value pub.1049896977
120 rdf:type schema:PropertyValue
121 N207bac4190574f9fbe7b8f67df3120e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Aged
123 rdf:type schema:DefinedTerm
124 N32d1542ee3ba462f9bfc64ccd8fece32 rdf:first sg:person.01242114114.58
125 rdf:rest rdf:nil
126 N3a9100710e4e4f35b3663c34816bcb1a rdf:first sg:person.01050575541.13
127 rdf:rest Ndaad90272dd042e38c5048cf2234cfe3
128 N4149360ca9154c77a6982a3675fb813d rdf:first sg:person.01236253014.51
129 rdf:rest N3a9100710e4e4f35b3663c34816bcb1a
130 N552ad053cd0846cab77d39c5017b2985 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Female
132 rdf:type schema:DefinedTerm
133 N552c8e9faf6f43b1b8c0327e62c6077b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Survival Rate
135 rdf:type schema:DefinedTerm
136 N589365064c884e83811b48d021b6470b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Prognosis
138 rdf:type schema:DefinedTerm
139 N5c7ac7a297984eb18fef522f94943d5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Follow-Up Studies
141 rdf:type schema:DefinedTerm
142 N67e43da2200444bbae58eb35617a3bac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Skin Neoplasms
144 rdf:type schema:DefinedTerm
145 N74c7be69055b46ecb74640b3c97552f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Neoplasm Staging
147 rdf:type schema:DefinedTerm
148 N859498c7489c4e4c93bff0bb8f66b839 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Humans
150 rdf:type schema:DefinedTerm
151 N87d11594e8584a99ab0299e8f68bcf09 rdf:first sg:person.01157103223.12
152 rdf:rest N004d71607f8a4e23acceecda9618f1a3
153 Nae28958ec61349c9b1b4af5c9993377a schema:name pubmed_id
154 schema:value 23838913
155 rdf:type schema:PropertyValue
156 Nb4aa9de988054f77b83551c6a530a35b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Prospective Studies
158 rdf:type schema:DefinedTerm
159 Nb5f3c57052e54cbfa3b91136c78c1de6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Adult
161 rdf:type schema:DefinedTerm
162 Nba3a2376b19c4ce28de036135882e308 rdf:first sg:person.0726366600.25
163 rdf:rest N32d1542ee3ba462f9bfc64ccd8fece32
164 Ncf2c0839ac2345fa8dde1d8bc6ca01d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Male
166 rdf:type schema:DefinedTerm
167 Nd21be8f3c8ec431c87a6157dc1dfe175 schema:issueNumber 11
168 rdf:type schema:PublicationIssue
169 Nd2ed499f2b5a48ce917213c11867f177 schema:volumeNumber 20
170 rdf:type schema:PublicationVolume
171 Ndaad90272dd042e38c5048cf2234cfe3 rdf:first sg:person.01356724235.54
172 rdf:rest N87d11594e8584a99ab0299e8f68bcf09
173 Nebf551dcf5ef4bb592fffdec3fb821f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Middle Aged
175 rdf:type schema:DefinedTerm
176 Nf5823b9ce68e4fbc81e221a628684fdc schema:name Springer Nature - SN SciGraph project
177 rdf:type schema:Organization
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
182 schema:name Oncology and Carcinogenesis
183 rdf:type schema:DefinedTerm
184 sg:grant.2705241 http://pending.schema.org/fundedItem sg:pub.10.1245/s10434-013-3089-0
185 rdf:type schema:MonetaryGrant
186 sg:journal.1105545 schema:issn 1068-9265
187 1534-4681
188 schema:name Annals of Surgical Oncology
189 schema:publisher Springer Nature
190 rdf:type schema:Periodical
191 sg:person.01050575541.13 schema:affiliation grid-institutes:grid.51462.34
192 schema:familyName Chou
193 schema:givenName Joanne F.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050575541.13
195 rdf:type schema:Person
196 sg:person.01157103223.12 schema:affiliation grid-institutes:grid.51462.34
197 schema:familyName Brady
198 schema:givenName Mary S.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157103223.12
200 rdf:type schema:Person
201 sg:person.01236253014.51 schema:affiliation grid-institutes:grid.51462.34
202 schema:familyName Bello
203 schema:givenName Danielle M.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236253014.51
205 rdf:type schema:Person
206 sg:person.01242114114.58 schema:affiliation grid-institutes:grid.51462.34
207 schema:familyName Ariyan
208 schema:givenName Charlotte E.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242114114.58
210 rdf:type schema:Person
211 sg:person.01356724235.54 schema:affiliation grid-institutes:grid.51462.34
212 schema:familyName Panageas
213 schema:givenName Katherine S.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356724235.54
215 rdf:type schema:Person
216 sg:person.0625226217.29 schema:affiliation grid-institutes:grid.51462.34
217 schema:familyName Coit
218 schema:givenName Daniel G.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625226217.29
220 rdf:type schema:Person
221 sg:person.0726366600.25 schema:affiliation grid-institutes:grid.51462.34
222 schema:familyName Carvajal
223 schema:givenName Richard D.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25
225 rdf:type schema:Person
226 sg:pub.10.1007/b97377 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013400699
227 https://doi.org/10.1007/b97377
228 rdf:type schema:CreativeWork
229 sg:pub.10.1007/s10434-000-0160-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035530171
230 https://doi.org/10.1007/s10434-000-0160-4
231 rdf:type schema:CreativeWork
232 sg:pub.10.1023/a:1008872014889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016443286
233 https://doi.org/10.1023/a:1008872014889
234 rdf:type schema:CreativeWork
235 sg:pub.10.1023/a:1018460227927 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004366948
236 https://doi.org/10.1023/a:1018460227927
237 rdf:type schema:CreativeWork
238 sg:pub.10.1038/ng.2359 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021618497
239 https://doi.org/10.1038/ng.2359
240 rdf:type schema:CreativeWork
241 sg:pub.10.1186/1757-1146-1-11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050685050
242 https://doi.org/10.1186/1757-1146-1-11
243 rdf:type schema:CreativeWork
244 sg:pub.10.1245/aso.2005.03.074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038975406
245 https://doi.org/10.1245/aso.2005.03.074
246 rdf:type schema:CreativeWork
247 sg:pub.10.1245/s10434-011-1706-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052825046
248 https://doi.org/10.1245/s10434-011-1706-3
249 rdf:type schema:CreativeWork
250 grid-institutes:grid.51462.34 schema:alternateName Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
251 Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
252 Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
253 schema:name Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
254 Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
255 Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
256 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...